A coffee you used to enjoy seems bitter. A familiar meal suddenly tastes flat. Can a GLP-1 medicine have something to do with it? A change in taste is possible, and the U.S. Wegovy label records reports of altered taste in weight-reduction trials. Research that tests people’s ability to identify tastes gives a less straightforward answer. Two small studies found differences in opposite directions, using different tests and groups of people.
A Food Research International review published online November 2, 2026, takes up that uncertainty as a question for food makers. The authors consider how changes in taste or food preference could matter for new products. The review’s abstract describes limited research on aroma and texture preferences and on whether changes last. For someone wondering why dinner tastes different, the most instructive evidence is what the original studies actually asked people to do. Floyd and colleagues’ review
Bitterness, flat flavor and less interest in food
The tongue can recognize bitterness and sweetness. The aroma of coffee also reaches the nose as you drink, contributing to what you experience as flavor. Texture and temperature play a part too. A taste test isolates some of these sensations. It asks a person to identify a taste, often at different concentrations, whereas how much someone enjoys a coffee is a judgment about the whole drink. NIH guide to taste disorders
There is also the question of how often the coffee comes to mind. The recent Wegovy studies on food noise asked about food thoughts. Someone could think about a favorite food less often and still recognize its sweetness just as easily. A food-thought score, a taste test and enjoyment at the table each capture a different part of the experience.
Why two taste tests point in different directions
In a 16-week trial, researchers randomized 30 adult women with obesity and polycystic ovary syndrome (PCOS) to weekly semaglutide or placebo. The semaglutide study used 16 strips that delivered four basic tastes at four concentrations. The researchers reported an estimated 2.5-point difference in overall taste recognition in favor of semaglutide on the 16-point test. The 95% confidence interval was 1.7 to 3.3 points. The trial excluded people with diabetes. It offers direct evidence for that particular group over a short period, and the score measures recognition of the strips. Published trial abstract · ClinicalTrials.gov registration
A different research team tested 46 people already taking GLP-1 medicines and 46 people matched on age, sex, smoking and COVID-19 history. Current users averaged about 29 points on a 53-item taste test, compared with about 41 among controls. The study had no measurements from before treatment, so it could compare the groups only as they were when tested. Possible differences already present before treatment could contribute to the gap. A separate test of smell identification showed no statistically significant difference in this sample. Khan and colleagues’ study abstract
Those figures sit on different scales. The first is an estimate from assigning one drug or placebo in a narrowly defined group. The second is a snapshot across people using medicines in the class. Together they leave the direction and size of any change uncertain for other patients and products. For more on what each design supports, see our guide to randomized trials and real-world evidence.
What the Wegovy label measures
In adult weight-reduction trials of Wegovy injections, 1.7% of adults receiving the drug and 0.5% receiving placebo reported dysgeusia, according to the U.S. prescribing information. Dysgeusia can feel like a persistent metallic or otherwise unpleasant taste. The figures describe a reported adverse reaction in those trials. They leave questions open about milder changes in flavor, how long a change might last and what percentage of people using other GLP-1 medicines experience one. Wegovy prescribing information, Section 6.1 · NIH guide to taste disorders
How to describe a change at a follow-up
If a change persists or makes it harder to eat, bring a specific example to your care team. It can help to describe when you first noticed it, whether it affects many foods or just a few, and whether aromas changed too. Mention a taste that lingers between meals, a recent illness or changes in other medicines if they apply. A taste or smell change can have several causes, and that history helps a clinician decide what to assess. Our guide to eating when GLP-1 treatment changes appetite covers a related concern, staying nourished when meals are harder to finish. NIH guidance on evaluation



